Glucosylceramides stimulate murine epidermal hyperproliferation.
about
Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolismCloning and expression of glycolipid transfer protein from bovine and porcine brainDysregulated sphingolipid metabolism in endometriosisThe impact of sphingosine kinase-1 in head and neck cancer.Age-dependent changes in the sphingolipid composition of mouse CD4+ T cell membranes and immune synapses implicate glucosylceramides in age-related T cell dysfunctionSkin ultrastructural findings in type 2 Gaucher disease: diagnostic implications.Neurofibromatosis-like phenotype in Drosophila caused by lack of glucosylceramide extensionPreferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase.Epidermal barrier: Adverse and beneficial changes induced by ultraviolet B irradiation depending on the exposure dose and time (Review)Delineating pathological pathways in a chemically induced mouse model of Gaucher disease.Effect of an inhibitor of glucosylceramide synthesis on cultured human keratinocytes.Regulation of glycosphingolipid metabolism in liver during the acute phase response.Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease.
P2860
Q24616344-4D51265F-1691-400D-B0A5-74C5CE8D3C4BQ24650897-4EC61D97-38F4-4CAB-A4A3-BDE70E75BA51Q33570165-042E3E8B-FB28-4343-8AEF-743054B1A639Q33649748-49CF8BD0-6348-4167-91FA-AED354579541Q34460494-FE8AD90B-2299-4888-A975-0C15FA6E2937Q35573474-17CC43D6-575B-40AC-BBF3-60D9273C4819Q35935658-7412D274-7411-4AC5-AC4B-615BA779FC8DQ36619817-1250E10B-E3E4-44F3-8AF2-35F895F58EF4Q37207339-D2FCA8CE-97C9-47BD-86D2-B04CFD839BFAQ39730152-B99D9A82-4CBE-4FEB-9863-3FA32DE78B58Q40861425-4F9D997E-31F6-4427-B549-51683647BA58Q41676991-307F5CF3-9CB3-4C17-BB51-B7ED437D1D1AQ41681702-9336FB4B-8A84-41F4-927B-E24A53BA8D2BQ50436260-27A21125-ACFC-4F69-B0AF-19AE80B044D6Q52010935-93A842BC-6F8E-45DE-AEDF-B9A429457700
P2860
Glucosylceramides stimulate murine epidermal hyperproliferation.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Glucosylceramides stimulate murine epidermal hyperproliferation.
@ast
Glucosylceramides stimulate murine epidermal hyperproliferation.
@en
Glucosylceramides stimulate murine epidermal hyperproliferation.
@nl
type
label
Glucosylceramides stimulate murine epidermal hyperproliferation.
@ast
Glucosylceramides stimulate murine epidermal hyperproliferation.
@en
Glucosylceramides stimulate murine epidermal hyperproliferation.
@nl
prefLabel
Glucosylceramides stimulate murine epidermal hyperproliferation.
@ast
Glucosylceramides stimulate murine epidermal hyperproliferation.
@en
Glucosylceramides stimulate murine epidermal hyperproliferation.
@nl
P2093
P2860
P356
P1476
Glucosylceramides stimulate murine epidermal hyperproliferation.
@en
P2093
W M Holleran
P2860
P304
P356
10.1172/JCI117997
P407
P577
1995-06-01T00:00:00Z